Endogenous opioid peptides and opiate drugs are known to aŠect the development of the nervous system. b-Casomorphins (b-CMs) belong to a family of exogenous opioid peptides derived from the milk protein b-casein by proteolytic fragmentation. We investigated the eŠects of various fragments and analogues of b-CM on neurite outgrowth in Neuro-2a mouse neuroblastoma cells. The fragments b-CM-5 to -9 and b-CM-5 amide stimulated neurite outgrowth. Fragments shorter than b-CM-5 (b-CM-3, -4, and b-CM-4 amide) and longer than b-CM-9 (b-CM-13 and -21) had no eŠects. The activity of b-CMs to promote neurite outgrowth does not correlate with their opioid activity in guineapig ileum. The eŠect of the most potent fragment, b-CM-5, was prevented by the m-opioid receptor-selective antagonist D-Phe-Cys 2 -Tyr 3 -D-Trp-Orn 5 -Thr 6 -Pen 7 -Thr 8 -NH 2 (CTOP), or by pretreatment with pertussis toxin. These results suggest that the stimulatory eŠects of b-CMs on neurite outgrowth were mediated through G protein-coupled m-opioid receptors.
b-casomorphins (b-CMs) are opioid peptides, which are released from the milk protein, b-casein by proteolytic fragmentation. b-CM-7 (Tyr-Pro-Phe-Pro-Gly-Pro-Ile) was theˆrst b-CM isolated, from peptone of bovine casein. 1) [Pro 8 ]-b-CM-8 and b-CM-4 amide (morphiceptin) were also isolated from an enzymatic digest of casein. 2) They all contain the common N-terminal amino acid sequence Tyr-Pro-Phe-Pro, corresponding to the peptidic sequence 60-63 of bovine b-casein and have preferential m-opioid receptor agonist activity. 3) Afterward, the amino acid sequences of b-CM were found in analo-gous positions of b-casein in many species of mammals. 4) b-CMs have various eŠects as neurotransmitters and neuromodulators on the central nervous, endocrine, cardiovascular, and gastrointestinal systems. 5) Evidence for the liberation of b-CMs from casein into the intestinal lumen of mammals after the intake of milk or a casein-containing diet under in vivo conditions, has already been obtained. 6, 7) Recently, Jinsmaa and Yoshikawa 8) reported the conditions for the release of b-CM-7 from bovine b-casein by gastrointestinal proteases in vitro. In their study, long b-CMs (b-CM-9, -13, and -21) were also released. As to the fragments longer than b-CM-7, there are two types ([His 8 ]-b-CMs and [Pro 8 ]b-CMs) derived from diŠerent genetic variants of b-casein containing His or Pro at the 67th position.
Endogenous opioid peptides and opiate drugs are known to aŠect the development of the nervous system, including neuroblast replication, survival, and diŠerentiation of neuronal cells. 9, 10) While the inhibitory activity of opioids against the growth and diŠerentiation of neurons is well recognized, the stimulatory eŠects are less well established. Recently we reported the stimulatory eŠects of b-CM-5 on neurite outgrowth in Neuro-2a mouse neuroblastoma cells. 11) Because milk is the only source of nutrition for newborn mammals, b-CMs may in‰uence neural development during the suckling period. Further, b-CMs may provide medical or health beneˆts, including the prevention and treatment of neurodegenerative disease and neuronal injury.
In this study, to build on our previous report we tested the eŠects of various b-CM fragments and some analogues on neurite outgrowth in Neuro-2a cells, and the participation of the opioid receptor in the stimulatory eŠects of b-CMs.
Materials and Methods
Materials. b-CM-5 and -7 were obtained from Peptide Institute, Inc. (Osaka, Japan) and b-CM-3, -4, -6, morphiceptin, [D-Ala 2 ]-b-CM-5, [D-Pro 2 ]-b-CM-5, and b-CM-5 amide from Bachem (Bubendorf, Switzerland). Des-Tyr-b-CM-7, naloxone, and naltrindole were from Sigma (St. Louis, MO, USA). D-Phe-Cys 2 -Tyr 3 -D-Trp-Orn 5 -Thr 6 -Pen 7 -Thr 8 -NH 2 (CTOP) and nor-binaltorphimine (nor-BNI) were from Tocris Cookson Inc. (Ballwin, MO, USA). Pertussis toxin was from List Biological Laboratories Inc. (Campbell, CA, USA). Other b-CM fragments were synthesized using SAM-2 (Biosearch, San Rafael, CA, USA) and PS3 (Rainin, Woburn, MA, USA) peptide synthesizers by the Fmoc method. Dulbecco's modiˆed Eagle's medium (DMEM), Ham's F-12 medium, kanamycin, fetal bovine serum (FBS) and N2 supplement were from Gibco Life Sciences (Grand Island, NY, USA). The cAMP RIA kit was from Yamasa Shouyu (Chiba, Japan). 3isobutyl-methyl-xanthine (IBMX) and forskolin were from Wako Pure Chemical Industries (Osaka, Japan). Plastic tissue culture dishes and plates were from Iwaki (Chiba, Japan).
Cell culture. The Neuro-2a cell line (IFO 50081) was obtained from the Institute for Fermentation, Osaka (Osaka, Japan). Cells were grown on plastic dishes in DMEM supplemented with 10z FBS and kanamycin (50 mg W ml) at 379 C in a humidiˆed atmosphere of 5z CO2 and 95z air.
Neurite outgrowth assay. The neurite outgrowth assay was done as described previously. 11) Brie‰y, Neuro-2a cells in exponential growth phase were plated in 24-well plates at a density of 1×10 4 cells per ml in each well, and grown for 24 h in DMEM with 1z FBS and kanamycin (50 mg W ml). After removal of the medium, 1 ml of serum-free chemically deˆned N2 medium 12) (50 W 50 mixture of Ham's F-12 and DMEM containing N2 supplement) with or without test compound(s) was added. After culturing for 3 h, each culture wasˆxed with 1z glutaraldehyde in phosphate-buŠered saline (PBS). In this experiment, to avoid the eŠects of serum, which may contain endogenous opioids, we used serum-free medium. Neurite formation in this cell line is induced, reportedly, on serum removal. 13) Under our experimental conditions, neuritogenesis in Neuro-2a cells was evident after serum removal for 1 h, and then the percentage of cells bearing neurites increased gradually. The neurite outgrowth assay was done after switching from serum-containing to serum-free medium with or without test compound(s) for 3 h. The outgrowth of neurites from cells was monitored under a phase-contrast microscope. Cells bearing neurites of at least one cell body in length were scored as positive. At least 200 cells were scored in each well toˆnd the percentage of cells with neurites. Cultures were coded and counted without knowledge of their treatment. Data are given as the mean±SEM values from two or three separate experiments with quadruplicate measurements. Statistical comparisons were made using one-way ANOVA followed by ScheŠe's test or Student's t-test. The signiˆcance level was set at Pº0.05.
Guinea-pig ileum (GPI) assay. The opioid activity of various b-CM fragments and analogues was measured by the GPI assay as described previously. 8) IC 50 means the concentration of peptide inhibiting maximum electrically-induced contraction by 50z.
Measurement of cAMP accumulation. Neuro-2a cells in an exponential growth phase were plated in 24-well plates at a density of 4×10 5 cells per ml in each well, and grown in DMEM with 1z FBS and kanamycin (50 mg W ml) at 379 C in a humidiˆed atmosphere of 5z CO2 and 95z air. After 24 h, the medium was removed from the individual wells, and replaced with 0.5 ml of DMEM supplemented with 0.5 mM 3-isobutyl-methyl-xanthine (IBMX) at 379 C. After 10 min, the reaction was started with the addition of 0.5 ml of DMEM containing b-CM-5 with or without 20 mM forskolin. After another 30 min, the medium was removed and the reaction was stopped by the addition of 1 ml of cold 6z trichloroacetic acid (TCA). The cells were disrupted by repeated freezing and thawing three times, and each cell extract was centrifuged at 10,000×g for 10 min at 49 C. The supernatant was freed from TCA by ether extractions, and the pellet saved for protein assay. The amount of cAMP recovered was then assayed by RIA according to the instructions of the manufacturer. The initial protein pellet from the TCA-treatment was dissolved in 1 N NaOH and a portion of the solution was assayed for protein.
Results

EŠects of b-CM fragments on neurite outgrowth
We tested the eŠects of various b-CM fragments on neurite outgrowth. In addition to naturally occurring b-CMs (see Introduction), several short fragments were also examined. [Val 0 , Pro 8 ]-b-CM-9 was present in the digest of b-casein treated with gastrointestinal proteases. 14) Table 1 summarizes the eŠects of b-CM fragments on neurite outgrowth. b-CM-5, b-CM-6, and [Pro 8 ]-b-CM-9 produced signiˆcant increases in the percentage of cells with neurites at concentrations over 10 -9 M. b-CM-7 also had a sig-niˆcant eŠect at concentrations over 10 -8 M. However, b-CM-5 was the most potent and e‹cacious with a maximum eŠect (52.1±1.5z, 
EŠects of b-CM analogues on neurite outgrowth
We next examined the eŠects of b-CM analogues on neurite outgrowth. The modiˆcation by amidation of the carboxy-terminal or by the substitution of D-Ala for L-Pro 2 of b-CMs increases the a‹nity for the opioid receptor 15, 16) and an L-conˆguration at the Pro 2 residue is required for opioid activity. 17, 18) A comparison of the eŠects of b-CM analogues is shown in Table 2 . The b-CM-5 amide produced a signiˆcant change at concentrations over 10 -8 M though the b-CM-4 amide (morphiceptin) was ineŠective. The b-CM-5 analogues in which L-Pro 2 was replaced by D-Ala or D-Pro also did not have a signiˆcant stimulatory eŠect.
Opioid activities of b-CMs in the GPI assay
In order toˆnd whether the activity of b-CMs to promote neurite outgrowth was correlated with their opioid activities, we measured the latter by inhibiting electrically-induced contractions of a guinea-pig ileum muscle preparation (GPI assay). The IC50 values are summarized in Table 3 . b-CM-5 and the b-CM-5 amide, which had a potent and e‹cacious stimulatory eŠect on neurite outgrowth, showed strong opioid activities. However, morphiceptin and [D-Ala 2 ]-b-CM-5, which had no stimulatory activity, showed stronger opioid activities than b-CM-5. Further, all fragments longer than b-CM-5 had similar IC50 values in the GPI assay, regardless of whether or not they had activity to promote neurite outgrowth. These results indicate that the stimulatory activities of b-CMs for neurite outgrowth do not The opioid activity of various b-CM fragments and analogs was measured by GPI assay as described in Materials and Methods. IC50 means the concentration of peptide inhibiting maximum electrically-induced contraction by 50z. correlate with their opioid potencies in the GPI assay.
EŠects of opioid antagonists and pertussis toxin (PTX) on the neurite outgrowth-stimulating activity of b-CM-5
The eŠects of selective opioid antagonists on the stimulatory eŠect of b-CM-5 are shown in Fig. 1 . The eŠect of b-CM-5 (10 -6 M) was completely inhibited by 10 -6 M of naloxone and the m selective antagonist, CTOP. On the other hand, neither a d-selective antagonist, naltrindole, nor a k-selective antagonist, nor-BNI, blocked the stimulatory eŠect of b-CM-5. Toˆnd whether the G protein system was involved in the eŠect of b-CM-5, we pretreated cells with PTX (100 ng W ml) for 4 h. Under these conditions, b-CM-5 (10 -6 M) failed to have an eŠect (Fig. 2) .
EŠects of b-CM-5 on cAMP level in Neuro-2a cells
Opioid receptors are known to act via G proteins to inhibit adenylyl cyclase, 19) whereas opioids also have stimulatory eŠects on cAMP production. 20) Since reagents that elevate intracellular cAMP levels promote neurite outgrowth in this cell line, 21) we tested the eŠects of b-CM-5 on cAMP levels. Table 4 shows that 10 -6 M of b-CM-5 reduced the level of forskolin-stimulated cAMP production by 22z, and it had no eŠect on the basal cAMP level. Thus, the b-CMs-stimulated neurite outgrowth did not involve the elevation of intracellular cAMP level.
Discussion
We previously reported that the stimulatory action of b-CM-5 was blocked by a non-selective antagonist, naloxone, and that DAMGO had a similar eŠect, which was very weak. 11) Therefore, the eŠect of b-CM-5 on neurite outgrowth is expected to be regulated via an opioid receptor, which has m-like characteristics. From the structure-activity relationships of b-CM fragments and analogues in this study, a‹nity for the opioid receptors was concluded to be essential for the activity to stimulate neurite outgrowth. [Val 0 , Pro 8 ]-b-CM-9 and des-Tyr-b-CM-7 were ineŠective, indicating that the N-terminal tyrosine residue was essential for the activity to stimulate neurite outgrowth. It is known that the presence of a tyrosine residue at the N-terminal end is an important structural motif thatˆt into the binding site of the opioid receptors. 17) b-CM-3, b-CM-4, and [D-Pro 2 ]b-CM-5 which reportedly show little a‹nity for opioid receptors, 17, 18, 22) were also ineŠective in Neuro-2a cells. On the other hands, all peptides that stimulated neurite outgrowth had the opioid activities in the GPI assay, without exception. The eŠect of b-CM-5 was prevented by co-administration of CTOP or by pretreatment with PTX. These results suggest that the G protein-coupled m-opioid receptor is involved in the stimulatory eŠects of b-CMs on neurite outgrowth in Neuro-2a cells. However, the activity to stimulate neurite outgrowth was only shown by fragments of a certain length (b-CM-5 to -9).
An interesting observation in this study is that the stimulatory activities of b-CMs did not correlate with their opioid activities in the GPI assay. Notably, morphiceptin and [D-Ala 2 ]-b-CM-5 did not stimulate neurite outgrowth despite having potent opioid activity in the GPI assay ( Table 2, 3) . A similar result was obtained by us in terms of neuronal survival-promoting eŠects of b-CM-5, b-CM-7 and morphiceptin. 23) The e‹cacy of morphiceptin on neuronal survival was much less than that of b-CM-5 or -7 at high concentrations (micromolar range). The inconsistency may be explained by the experimental diŠerences of treatment periods with opioids. The opioid activity measured in the GPI assay re‰ected the acute action of the peptide, as compared with the neurite outgrowth activity induced by prolonged exposure to opioids. Thus, the lack or weakness of the activity to promote neurite outgrowth by morphiceptin and [D-Ala 2 ]-b-CM-5 might be due to the desensitization of the m-receptor. Receptor internalization and downregulation in response to chronic agonist treatment contribute to receptor desensitization, which aŠects cellular responsiveness to ligands. The potency and e‹cacy of signal transduction of opioids are related to desensitization, and partial agonists caused less internalization of opioid receptors than full agonists in neuroblastoma 24) and in vivo. 25) Thus, stimulation of m-receptors with b-CM-5, -6, and -7 might result in appropriate e‹cacies for signaling subsequent to neurite outgrowth-stimulation without the loss of mreceptors from the cell surface. On the other hand, the reason the longer b-CM fragments had less neurite outgrowth-stimulatory activity, did not appear to be desensitization, considering their low levels of opioid activity in the GPI assay. The m-receptors have been subdivided into m1 and m2 types. 26) The m1receptors display a high a‹nity for both opioid peptides and opiate alkaloids. In contrast, the m2receptor has a higher a‹nity for opiate alkaloids than for opioid peptides. It is known that the GPI preparation mainly contains m2 receptors. 26) The failure of long b-CMs to stimulate neurite outgrowth might be due to the ligand selectivities of opioid receptors in the Neuro-2a cells. Further study is required to characterize the m-receptors in Neuro-2a cells.
Opioids have been shown to in‰uence neuritic diŠerentiation in vivo and in vitro. Addition of low concentrations of various enkephalin and endorphin peptides increased the neurite outgrowth of superior cervical ganglia explants from rodents. 27) Morphine was reported to show biphasic dose-dependent inhibitory and stimulatory eŠects on neuritogenesis in PC12 pheochromocytoma in the presence of nerve growth factor (NGF); the eŠect might be mediated via a receptor having d-like characteristics. 28) On the other hand, perinatal administration of morphine induced a reduction in dendritic growth in the cerebral cortex of 5-day-old rats. 29) Morphine decreased neurite arborization in neuron-enriched cultures derived from chick embryonic brain, 30) and reduced the length of Purkinje cell dendrites in organotypic explants of cerebellum from 1-day-old mice. 31) Further, Met-enkephalin and [D-Ala 2 ]-deltorphin II reduced the diŠerentiation of cerebellar external granular layer neurons from postnatal mice through d2 receptor subtypes. 32) Together, theseˆndings suggest that the eŠects of opioids on neuronal diŠerentiation are variable and cell-type speciˆc. Our study suggests m-opioid receptor agonists to be stimulators of neurite outgrowth.
At present, the intracellular signaling mechanisms for neurite outgrowth after the stimulation of G protein-coupled m-opioid receptors by b-CMs are not clear. In neuronal cells, reagents that elevate intracellular cAMP levels evoke diŠerentiation signals. 33) In the present study, the b-CMs-stimulated neurite outgrowth did not involve the regulation of intracellular cAMP. It was recently reported that opioids can activate ras W mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinase (ERK) in vitro and in vivo. 34, 35) ERK1 W 2 activity is known to play a role in the neuritogenesis of Neuro-2a cells. 36) Thus, b-CMs may trigger a G protein-mediated activation of a PI3K W MAPK signaling pathway, subsequently to elongation of neurite.
In summary, theseˆndings suggest that m-opioid receptor activation stimulates neuronal diŠerentiation via a G protein transduction system. Interestingly, some b-CM fragments (b-CM-5 to -9) had this stimulatory eŠect. Apart from their possible role as neurotransmitters and neuromodulators, b-CMs may also in‰uence neural development or regeneration.
